Get started
Cumberland Pharmaceuticals Inc.Cumberland Pharmaceuticals Inc.Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

CPIX chart


Full chart

CPIX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪35.25 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.77 USD
Net income (FY)
‪−6.28 M‬ USD
Revenue (FY)
‪39.55 M‬ USD
Shares float
‪7.85 M‬
Beta (1Y)
−0.15

Employees


Employees (FY)
91
Change (1Y)
+6 +7.06%
Revenue / Employee (1Y)
‪434.64 K‬ USD
Net income / Employee (1Y)
‪−69.00 K‬ USD

About Cumberland Pharmaceuticals Inc.


Sector
Health Technology
CEO
A. J. Kazimi
Headquarters
Nashville
Website
cumberlandpharma.com
Founded
1999
FIGI
BBG000R93GV7
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. Its products include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, Sancuso, Boxaban, Vasculan. Dyscorban, and RediTrex. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CPIX news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CPIX is 2.35 USD — it has increased by 11.56% in the past 24 hours. Watch Cumberland Pharmaceuticals Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cumberland Pharmaceuticals Inc. stocks are traded under the ticker CPIX.
CPIX stock has risen by 12.56% compared to the previous week, the month change is a 141.35% rise, over the last year Cumberland Pharmaceuticals Inc. has showed a 31.26% increase.
CPIX reached its all-time high on Aug 11, 2009 with the price of 17.75 USD, and its all-time low was 1.04 USD and was reached on Nov 25, 2024. View more price dynamics on CPIX chart.
See other stocks reaching their highest and lowest prices.
CPIX stock is 11.41% volatile and has beta coefficient of −0.15. Track Cumberland Pharmaceuticals Inc. stock price on the chart and check out the list of the most volatile stocks — is Cumberland Pharmaceuticals Inc. there?
Today Cumberland Pharmaceuticals Inc. has the market capitalization of ‪33.00 M‬, it has increased by 7.26% over the last week.
Yes, you can track Cumberland Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
Cumberland Pharmaceuticals Inc. is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
CPIX net income for the last quarter is ‪−1.54 M‬ USD, while the quarter before that showed ‪−1.09 M‬ USD of net income which accounts for −42.23% change. Track more Cumberland Pharmaceuticals Inc. financial stats to get the full picture.
No, CPIX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 91.00 employees. See our rating of the largest employees — is Cumberland Pharmaceuticals Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cumberland Pharmaceuticals Inc. EBITDA is ‪−1.29 M‬ USD, and current EBITDA margin is −1.80%. See more stats in Cumberland Pharmaceuticals Inc. financial statements.
Like other stocks, CPIX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cumberland Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cumberland Pharmaceuticals Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cumberland Pharmaceuticals Inc. stock shows the buy signal. See more of Cumberland Pharmaceuticals Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.